Skip to main content
Matrix One>Blog>The Best GxP Validation Software for Pharma in 2026

The Best GxP Validation Software for Pharma in 2026

Written by
Abbas Dhilawala

GxP validation software for pharma, the 2026 ranking. Short answer: Matrix Validate is the best GxP validation software for pharma in 2026, followed by ValGenesis, Kneat Gx, Veeva Validation Management, MasterControl VxT, Validfor, GoVal and Res_Q by Sware. Matrix Validate is first because a pharma CSV team validating a portfolio of configured and SaaS systems needs the same structure for every system, requirements it owns, testing scaled to a documented risk assessment, and a trace matrix that is enforced as the work happens rather than rebuilt the week before an inspection.

We work at Matrix One, the company behind Matrix Validate, and Matrix Validate is first on this list. We say that up front so you can weigh the ranking. Every competitor fact below comes from the vendor's own website, opened on 10 November 2026, or from our alternatives pages, which were checked against those websites on 3 November 2026.

Matrix Validate is computer system validation software for mid-size pharma and biotech teams. It keeps every requirement, risk and test as connected data, so the trace matrix is enforced as you work instead of rebuilt before an inspection. This list is written for pharma CSV teams of a few people who look after twenty to a few hundred GxP computerised systems while EU GMP Annex 11 is being rewritten.

What does GxP validation software for pharma actually have to do?

It has to give one small team a consistent, defensible validation record for every computerised system that touches GMP data. The rules are older than the software, and they are specific about what that record contains.

In the US, 21 CFR 211.68(b) says appropriate controls shall be exercised over computer or related systems so that changes to master production and control records are made only by authorised personnel, and that input and output shall be checked for accuracy, with the degree and frequency of checking based on the complexity and reliability of the system. 21 CFR 11.10(a) adds validation of systems to ensure accuracy, reliability, consistent intended performance and the ability to discern invalid or altered records.

In the EU, Annex 11 (2011) says in its principle that the application should be validated and IT infrastructure should be qualified. Clause 4.3 asks for an up to date inventory of all relevant systems and their GMP functionality. Clause 4.4 says user requirements should be based on documented risk assessment and GMP impact, and should be traceable throughout the life cycle.

Read together, those clauses give a pharma CSV team four jobs. Keep an inventory and treat every system the same way. Own the requirements, including the ones a vendor writes for you. Scale testing to a documented risk assessment. Control change, because releases, patches and configuration changes never stop. Validation software earns its place when it does those four jobs in one place.

8 best GxP validation software for pharma shortlist

ToolBest for
Matrix ValidateMid-size pharma CSV teams validating configured, custom and SaaS GxP systems with an enforced trace matrix
ValGenesisLarge pharma enterprises running validation and process lifecycle work on one platform
Kneat GxGlobal pharma organisations digitising many validation types across sites
Veeva Validation ManagementPharma companies already running Veeva QualityDocs and Veeva QMS
MasterControl VxTPharma teams validating MasterControl through each upgrade
ValidforPharma enterprises validating large ERP, MES, LIMS and QMS estates with AI agents
GoValPharma and CDMO teams moving IQ, OQ and PQ off paper
Res_Q by SwarePharma IT teams handling parallel change across ERP and other continuously changing systems

Which tool fits which kind of pharma team, at a glance?

ToolBuilt forStrongest on
Matrix ValidateMid-size pharma, biotech and combination product CSV teamsRequirements, risk and tests as connected items; trace rules; signed documents from live data
ValGenesisLarge enterprises; 30 of the top 50 life sciences companies, by its own countBreadth: iVal for validation, iClean for cleaning, iCPV for process verification
Kneat GxGlobal life sciences; 9 of the top 10, by its own countMany validation types on one platform, 100% remote CSV
Veeva Validation ManagementVeeva Vault quality customersUnified with QualityDocs and QMS, single audit trail
MasterControl VxTMasterControl customersRisk assessment and testing recommendations for MasterControl upgrades
ValidforHeads of QA, pharma enterprises, digital transformation teamsAI-native lifecycle with change, periodic review and deviation modules
GoValPharma, biotech and CDMOsGAMP 5 category classification that generates proportionate protocols
Res_Q by SwareLife sciences ITAutomated impact assessment across parallel changes

Read the table as a map of fit, not a scorecard. The question that sorts most pharma buyers is the first one in the second column: is your validation programme mostly computerised systems, or does it also include facilities, equipment, cleaning and process validation at scale?

How did we rank them?

CriterionWhat it means
Portfolio consistencyEvery system validated with the same project structure, template and approval route
Owned, traceable requirementsURS, FS and DS as approved items traced to risk and test, per Annex 11 clause 4.4
Risk-scaled testingPatient safety, product quality and data integrity scored per requirement, testing sized to match
Contemporaneous executionPass or fail, comments and evidence recorded against each step at the time of testing
Change and periodic evaluationRelease impact found by query, retesting limited to what changed, inputs for Annex 11 clause 11
Fit for a mid-size teamUsable by a CSV team of two to ten without an enterprise rollout

We weighted the first two most heavily. A pharma company with 80 systems rarely fails an inspection on one bad protocol. It struggles when no two validations look alike, when requirements cannot be traced from URS to test, and when nobody can show why a function received the testing it did. Breadth across validation types counted, but it counted less, because this list is about computerised systems.

Which 8 tools made the list, and in what order?

1. Matrix Validate

Matrix Validate is computer system validation software from Matrix One for mid-size pharma, biotech and combination product companies, typically 100 to 3,000 people. It validates eQMS, LIMS, ERP, document management, lab software, cloud and SaaS applications and tools built in-house, mainly GAMP 5 categories 4 and 5, through the GAMP 5 V-model with CSA-style risk-based testing.

Each project starts from your own validation template. You record the system, vendor, version and GAMP 5 category, and set who reviews and approves. One project per system, or several systems in one project, organised the way your SOPs already describe. That is what keeps eighty validations looking like one programme.

URS, FS and DS are individual items with their own ID, fields, version history and approval. Change one and every document that uses it updates. Each requirement or function is scored for patient safety, product quality and data integrity impact, the same three factors Annex 11 clause 1 names, and trace rules flag any requirement without a test and any risk without a control.

Testers run scripts step by step, with pass or fail, comments, screenshots and attachments recorded against each step as they test. Deviations are raised against the exact step, and failed steps can be linked to an issue or CAPA. The validation plan, trace matrix and validation summary report are generated from live data and signed with 21 CFR Part 11 compliant e-signatures that ask for full credentials at the point of signing.

Matrix Validate runs on the same platform as Matrix Req, which large pharma and medical device companies already use for validation work. Matrix One has built for life sciences since 2014, holds ISO 13485 and ISO 27001 certification, and has more than 500 life sciences customers worldwide.

2. ValGenesis

Built for large life sciences enterprises that want validation and process lifecycle work on one platform. ValGenesis says on valgenesis.com that 30 of the top 50 life sciences companies use its Smart GxP platform, and it describes its products as AI-native.

Its validation lifecycle suite includes iVal for validation and iClean for cleaning validation, and its process lifecycle suite includes iCMC and iCPV. On its computer system validation page ValGenesis says the platform captures step-level evidence and ALCOA+ audit trails, meeting 21 CFR Part 11 and Annex 11 requirements, and integrates with QMS, MES, PLM and ERP systems. See our ValGenesis alternative page for the full comparison.

3. Kneat Gx

Built for global life sciences organisations digitising many validation types across sites. Kneat says on kneat.com that 9 of the world's top 10 life sciences companies trust it, and its site lists use cases from computer systems and analytical instruments to cleaning, process, facilities and utilities.

Its CSV page says Kneat enables 100% remote computer systems validation and supports a document or data centric approach, with compliant electronic signatures and audit trail, real-time in-document collaboration and document automation. Our Kneat alternative page, checked against kneat.com on 3 November 2026, sets out where the two products differ.

4. Veeva Validation Management

Built for pharma companies that already run Veeva Vault QualityDocs and Veeva QMS. Veeva says Validation Management streamlines commissioning, qualification and validation across computerised systems, facilities, utilities, equipment and processes, and that it tracks system inventory, manages requirements and generates traceability and summary reports.

Veeva's product page lists it as announced in 2021, with a status of mature and 11 to 50 customers. It is unified with QualityDocs and QMS and captures all user actions, tasks and signatures in a single audit trail. Our Veeva Validation Management alternative page covers the comparison.

5. MasterControl Validation Excellence Tool (VxT)

Built for pharma teams that run MasterControl and need it validated through each upgrade. MasterControl says its patented Validation Excellence Tool assesses risks, offers testing recommendations and helps you focus on critical processes.

MasterControl sells VxT alongside validation services and a quarterly or annual validation subscription bundle, in which its consultants guide the effort from the VxT risk assessment through usage testing to a summary report. VxT is positioned for validating MasterControl itself, not as a general CSV tool for the rest of your portfolio.

6. Validfor

Built for heads of QA and validation, pharma enterprises and digital transformation teams. Validfor describes itself as an AI-native agentic digital validation platform, with change management, periodic review and deviation modules.

Its FAQ says it was designed for regulated industries, particularly the pharmaceutical sector, and lists the systems it can validate: ERP such as SAP and Oracle, MES such as PAS-X, LIMS such as LabWare and LabVantage, and QMS. That makes it a natural fit for a large estate of enterprise systems. Our Validfor alternative page has more.

7. GoVal

Built for pharma, biotech and contract manufacturing teams replacing paper protocols, at govalidation.com. GoVal's pharmaceutical validation page names GAMP 5, 21 CFR Part 11, EU Annex 11, IQ, OQ, PQ and ICH Q10.

GoVal says it classifies every system by GAMP 5 software category and automatically generates a proportionate URS, risk assessment, IQ, OQ and PQ protocols and validation summary report matched to each system's risk. It also lists periodic review and paperless qualification execution in the same environment.

8. Res_Q by Sware

Built for life sciences IT teams that validate software which changes continuously. Sware lists use cases on sware.com for Computer Software Assurance, quality management, infrastructure and integrations, and ERP system compliance.

For ERP, Sware says Res_Q manages multiple parallel changes in GxP and non-GxP systems through automated impact assessment. For a pharma company whose biggest validation burden is a large ERP with frequent releases, that is the use case to test in a demo.

For completeness: Ofni Systems FastVal says it incorporates GAMP 5 and ICH best practice, fits your existing SOPs and templates, and stores deliverables in FastVal or exports them as Word or PDF files. Valkit.ai, covered on our Valkit.ai alternative page, is another digital validation option for GxP teams.

What Matrix Validate is built for, and what you would buy alongside it

Matrix Validate is built for CSV teams at mid-size pharma, biotech and combination product companies that validate configured, custom and SaaS systems and want an enforced trace matrix from URS to signed summary report. It also covers qualification of in-house equipment: URS, DQ, IQ, OQ and PQ for lab instruments and test rigs, described on our equipment qualification page.

It focuses on computer system validation and in-house equipment qualification. Statistical process validation, cleaning validation, analytical method validation and paperless execution on the shop floor are not part of the current product, and the product page says so.

That is exactly where the large platforms are strong. ValGenesis covers cleaning validation in iClean and continued process verification in iCPV, and Kneat Gx and Veeva Validation Management cover facilities, utilities, equipment and process validation. A pharma site with a large commissioning and qualification programme would run one of those for the plant, and could run Matrix Validate for its computerised systems. We concede that axis openly.

What do you need in place before Matrix Validate works?

A validation tool reflects the process you give it. Four things make the first year go well:

  • IT and Quality owning it together, with the split written down: IT for the systems, Quality for the approvals.

  • A system inventory with GAMP 5 categories, which Annex 11 clause 4.3 expects anyway.

  • Named preparers and approvers for each system, so signatures route to the right people from the first project.

  • A scope decision: for now, Matrix Validate covers CSV and CSA plus simple in-house equipment qualification.

A typical starting point we see is a US biotech, two years commercial, with about 20 GxP systems validated in Word and PDF packages. The first project is usually the system with the most frequent vendor releases, because that is where rebuilding the trace matrix by hand costs the most time.

How do you keep twenty or two hundred validations consistent?

Start every system from the same template and the same item types. In a document-based programme, each system gets its own copy of the protocol template, and over a few years no two validations look the same. An inspector reading three packages notices that before reading a single test step.

The Annex 11 inventory in clause 4.3 is the natural anchor. Each entry carries the system's owner, vendor, version, GAMP 5 category and GMP functionality, and each entry points at one validation project built from the same structure. In Matrix Validate, the project records exactly those fields, so the inventory and the validation record are the same data rather than two documents that drift apart.

What does an inspector ask a pharma CSV team for?

Usually three things, quickly: the signed validation package for a named system, the evidence behind a specific test, and the change history since go-live. 21 CFR 211.180(c) says records shall be readily available for authorised inspection, and treats records that can be immediately retrieved by computer as meeting that requirement.

Part 11 sets the bar for the electronic copy. 21 CFR 11.10(b) asks for accurate and complete copies in human readable and electronic form, 11.10(e) for secure, computer-generated, time-stamped audit trails that do not obscure earlier entries, and 11.70 for signatures linked to their records so they cannot be excised or copied. Annex 11 clause 8.1 asks for clear printed copies of electronically stored data.

Matrix Validate generates the plan, trace matrix and summary report from live data, signs them, and exports them as PDFs to your QMS or document system. Every change to every item is recorded with who made it and when, alongside its version history.

How much testing does each GxP system really need?

As much as the risk justifies, and you have to write down why. Annex 11 clause 1 says decisions on the extent of validation should be based on a justified and documented risk assessment, taking into account patient safety, data integrity and product quality. 21 CFR 211.68(b) makes the same point for input and output checks: their degree and frequency depend on the complexity and reliability of the system.

ICH Q9(R1) applies the same principle across quality risk management, and FDA's Computer Software Assurance guidance of 3 February 2026 encourages focusing testing on the highest risk features. Its formal scope is production and quality system software for medical devices, but many pharma teams borrow its approach.

Matrix Validate scores each requirement or function for patient safety, product quality and data integrity impact, then links every control to the test that verifies it. When an inspector asks why a function received a light unscripted test, the answer is the risk record next to it.

How do you prove testing was recorded at the time it happened?

By recording it in the system during the test, not pasting it in afterwards. 21 CFR 211.100(b) says production and process control procedures shall be documented at the time of performance, and the same expectation runs through data integrity guidance for validation records.

Paper and PDF execution makes this hard to prove, because evidence is often added after the run. In Matrix Validate, testers record pass or fail, comments, screenshots and attachments against each step as they test, and each entry carries who made it and when.

How should pharma handle vendor releases and periodic evaluation?

Treat each release as a query against your validated baseline. Annex 11 clause 10 says changes, including configuration changes, should only be made in a controlled manner under a defined procedure. Clause 11 says systems should be periodically evaluated to confirm they remain in a valid state, looking at functionality, deviations, incidents, upgrade history and validation status.

In Matrix Validate you copy the validated project, apply the vendor's release notes, and impact analysis flags every requirement and test downstream of the change. Redlining shows exactly what changed and what needs retesting, so you rerun only the affected scripts. The upgrade history and deviation records an evaluation needs sit in the same project.

Matrix One does the same for its own platform. Matrix Validate comes with a pre-written validation project for the platform, and major releases are announced in advance with release notes and V&V reports, so revalidating the tool is a rerun, not a rewrite.

What changes when the revised Annex 11 arrives?

More than the page count. The European Commission consulted on a revised Annex 11, a revised Chapter 4 and a new Annex 22 on AI from 7 July to 7 October 2025. On 10 November 2026 the EudraLex Volume 4 page still lists Annex 11 as the January 2011 revision, so the 2011 text remains in force and no date of application has been set.

Our EU GMP Annex 11 page summarises six areas in the draft: owned system requirements, stricter audit trails, identity and access, suppliers and cloud services, electronic signatures with full re-authentication, and periodic review. Its six-step gap assessment works in that order: inventory, owned requirements, audit trails, access control, supplier agreements and periodic review. Matrix Validate holds the inventory, the requirements and the evidence for each step.

How do you validate SaaS systems you do not control?

Start from the supplier's documentation, then make it yours. Annex 11 clause 3.1 requires formal agreements with third parties, including clear statements of their responsibilities. Clause 3.2 says the need for a supplier audit should be based on a risk assessment, and clause 3.3 says documentation supplied with commercial off-the-shelf products should be reviewed to check that user requirements are fulfilled.

In Matrix Validate, vendor-supplied requirements can be imported, then reviewed, adapted and approved for your configuration, with full version history. That gives you owned requirements, which is what the draft revision asks for, without writing every URS from scratch.

What should a pharma team test in a demo of GxP validation software?

Run the same six checks with every vendor and keep the outputs:

  1. Set up two different systems from one template and compare the resulting projects side by side.

  2. Change one URS item and see which risks, tests and documents are flagged.

  3. Score three requirements for patient safety, product quality and data integrity, and show how the test depth follows.

  4. Execute a script with a failed step, raise a deviation against that step and attach evidence.

  5. Sign the summary report and check that the tool asks for full credentials at the point of signing.

  6. Load a vendor release note and show which scripts need to be rerun.

The first two checks are the pharma test, because they show whether a portfolio stays consistent as it grows. The last one shows what the next five years will cost you.

How do you move a validation programme out of Word and Excel?

Start with systems that are live and changing, not the archive. Packages approved in Word or PDF can stay as they are until the next change or periodic evaluation, when the system moves into the new tool. Annex 11 clause 4.8 applies if you migrate data: validation should include checks that data are not altered in value or meaning.

Matrix Validate imports existing requirements and test scripts from Word or Excel and structures them into items, so you do not start from a blank page. Our post on the best alternative to Excel and SharePoint for GxP validation covers that move in more detail.

Can AI help a pharma validation team?

Yes, if a named person approves every item it drafts. Several vendors here market AI: ValGenesis calls its platform AI-native, and Validfor describes itself as an agentic validation platform. The draft Annex 22 on AI, still a draft, keeps dynamic and generative AI out of critical GMP applications in its consultation text.

Matrix Validate's built-in AI drafts test cases from your requirements and finds traceability gaps. A person reviews and approves every item before it is saved, and nothing is approved automatically.

Where should you go next?

For the product, read the Matrix Validate overview and the computer system validation page. For the regulatory side, our best 21 CFR Part 11 compliant validation software post walks through Part 11 clause by clause.

For the wider category, see the best validation software, the best computer system validation software, the best validation lifecycle management system and the best validation software for biotech companies.

Summary: which GxP validation software is best for pharma in 2026?

Matrix Validate is the best GxP validation software for pharma in 2026, because a pharma CSV team validating a portfolio of configured and SaaS systems needs one structure for every system, requirements it owns, testing scaled to a documented risk assessment, and a trace matrix that is enforced as the work happens. It provides those as connected data, with signed documents generated from it, without an enterprise rollout.

  1. Matrix Validate: one structure for every GxP system, risk-scaled testing and an enforced trace matrix.

  2. ValGenesis: the broadest lifecycle platform for large pharma enterprises.

  3. Kneat Gx: many validation types digitised across global sites.

Last updated: 10 November 2026.

GxP validation software for pharma: frequently asked questions

Does a pharma company have to validate every computer system?

Every computerised system used as part of a GMP regulated activity falls under Annex 11, and 21 CFR 211.68 applies to computers used in drug manufacture, processing, packing and holding. The extent of validation is what varies.

Annex 11 clause 1 ties that extent to a documented risk assessment, so a low-risk system can carry much lighter testing than a system that calculates batch release data.

Does the record show who executed each test step?

In Matrix Validate, yes. Each step's pass or fail, comments, screenshots and attachments are recorded against that step as the tester works, and every change to every item is recorded with who made it and when.

Can it scale down to a team doing computer system validation only?

Yes. Matrix Validate is built for CSV teams validating configured, custom and SaaS systems, with simple in-house equipment qualification as an option. It does not require you to bring process, cleaning or shop-floor validation onto the same platform.

Does the AI approve anything, or is a human always in the loop?

A human is always in the loop. The built-in AI drafts test cases from your requirements and finds traceability gaps, and a person reviews and approves every item before it is saved.

Is the revised EU GMP Annex 11 in force yet?

No. The consultation closed on 7 October 2025, and on 10 November 2026 the European Commission's EudraLex Volume 4 page still lists the January 2011 revision of Annex 11. No final text or date of application has been published.

Does Matrix Validate replace our QMS or document management system?

It does not need to. It manages the validation lifecycle and exports signed PDFs, so validation documents can be filed in the QMS or document system you already use.

Do we need to validate Matrix Validate itself?

Yes, as with any GxP system. It comes with a pre-written validation project for the platform, with requirements, test cases, plan and report that your team reviews and executes, and major releases arrive with release notes and V&V reports.

Written by
Abbas Dhilawala
CTO

Abbas Dhilawala has spent 20 years writing software for an industry where mistakes have real consequences: medical devices and life sciences. That context tends to make you think differently about engineering, and about what it means to ship something. In 2016, he co-founded the company behind what is now Matrix Connect, on a straightforward premise: medical device companies needed a better way to capture, store, and act on device data in the cloud. What followed was a decade of building from scratch, earning HITRUST and ISO 13485 certifications, and eventually Matrix One acquired the company in 2025. He's now CTO at Matrix One, where he oversees the technical direction across their product portfolio. The current focus is rebuilding core products for the cloud and shipping AI features. He also runs a global engineering team, which he considers some of the most interesting work he's done.

View profile →